Professor and Div Director, Pediatric Oncology, Cincinnati Children's Hospital, University of Cincinnati College of Medicine
Pediatric Hematology & Oncology
Dr. John Perentesis, MD
|
|
Give Review
John Perentesis practices Pediatric Hematology & Oncology. He went to University of Michigan Medical School. He received 1 awards: "Fellow (FAAP)". Dr. John Perentesis is a published doctor. He has 57 papers published. The most current publication "Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies."
Publications
- A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase 1 Consor...
- Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study.
- Age dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1.
- A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary Acute myeloid leuke...
- AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent Acute myeloid ...
- A phase I trial of MK-2206 in children with refractory malignancies: A children's oncology group study.
- Differences in outcomes of newly diagnosed Acute myeloid leukemia for adolescent/young adult and younger patients: A Report from the Children's Oncology Group.
- Population Pharmacokinetics of Sirolimus in Pediatric Patients With Neurofibromatosis Type 1.
- Low dose decitabine in very high risk relapsed or refractory Acute myeloid leukaemia in children and young adults.
- Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory Acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group.
- Saccharomyces cerevisiae elongation factor 2. Mutagenesis of the histidine precursor of diphthamide yields a functional protein that is resistant to diphtheria toxin.
- Big babies and infant Leukemia: a role for insulin-like growth factor-1?
- Granulocyte-macrophage colony-stimulating factor receptor-targeted therapy of chemotherapy- and radiation-resistant human myeloid Leukemias.
- A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor.
- Why is age such an important independent prognostic factor in Acute lymphoblastic leukemia?
- Coinheritance of alpha-thalassemia-1 and hemoglobin E/beta zero-thalassemia: practical implications for neonatal screening and genetic counseling.
- In vivo biotherapy of HL-60 myeloid Leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulatin...
- Induction of apoptosis in multidrug-resistant and radiation-resistant Acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte...
- Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies.
- Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
- Protein toxin inhibitors of protein synthesis.
- Saccharomyces cerevisiae elongation factor 2. Genetic cloning, characterization of expression, and G-domain modeling.
- Expression of diphtheria toxin fragment A and hormone-toxin fusion proteins in toxin-resistant yeast mutants.
- Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor.
- Glutathione S-transferase polymorphisms in children with myeloid Leukemia: a Children's Cancer Group study.
- Recombinant fusion toxins directed against the human granulocyte-macrophage colony stimulating factor (GM-CSF) receptor.
- Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood Acute myeloid leukemia.
- Genetic predisposition and treatment-related Leukemia.
- Targeted therapies for high-risk Acute myeloid leukemia.
- RAS oncogene mutations and outcome of therapy for childhood Acute lymphoblastic leukemia.
- Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin''s Lymphoma at risk of treatment-related complications.
- DNA repair polymorphisms and outcome of chemotherapy for Acute myelogenous leukemia: a report from the Children''s Oncology Group.
- Autologous stem cell transplantation for high-risk Ewing''s sarcoma and other pediatric solid tumors.
- XPD Lys751Gln polymorphism in the etiology and outcome of childhood Acute myeloid leukemia: a Children''s Oncology Group report.
- FAS promoter polymorphism: outcome of childhood Acute myeloid leukemia. A children's oncology group report.
- Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Gr...
- MDM2 polymorphism increases susceptibility to childhood Acute myeloid leukemia: a report from the Children's Oncology Group.
- Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
- Tribute: the American Society of Pediatric Hematology/Oncology (ASPHO), 2011 Distinguished Career Award goes to Dr. William G. Woods.
- Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.
- Treating children with chronic myeloid Leukemia in the imatinib era: a therapeutic dilemma?
- Osteosarcoma in the first decade of life.
- Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood Acute lymphoblastic leukemia.
- Parental exposure to medications and hydrocarbons and ras mutations in children with Acute lymphoblastic leukemia: a report from the Children''s Oncology Group.
- XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin Disease.
- Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DN...
- Natural history of transient Myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.
- Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
- Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376).
- Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with Acute myeloid leukemia.
- Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery.
- Translocation (8;18;16)(p11;q21;p13). A new variant of t(8;16)(p11;p13) in Acute monoblastic leukemia: case report and review of the literature.
- Ethnicity and survival in childhood Acute myeloid leukemia: a report from the Children''s Oncology Group.
- Biphenotypic Leukemia: immunologic and morphologic evidence for a common lymphoid-myeloid progenitor in humans.
- Autologous stem cell transplantation for high-risk pediatric solid tumors.
- Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic Leukemia.
Schools
University of Mi Med Sch
University Of Minnesota
Conditions Treated
- Acute Leukemia
- Anemia
- Hodgkin's Disease
- Lymphoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
University of Minnesota at Fairview -
University of Michigan Medical School
Hospital
-
Cincinnati Children's Hospital Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Alexandra H. Filipovich, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Adrienne M. Hammill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariko D. Dewire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajaram Nagarajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kasiani Myers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryam Fouladi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Karen C. Burns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Parinda A. Mehta, MB
This Doctor is OpenDoctor Recommended.
|